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Abstract
Prions are units of propagation of an altered state of a protein or proteins; prions can propagate from organism to
organism, through cooption of other protein copies. Prions contain no necessary nucleic acids, and are important both as
both pathogenic agents, and as a potential force in epigenetic phenomena. The original prions were derived from a
misfolded form of the mammalian Prion Protein PrP. Infection by these prions causes neurodegenerative diseases. Other
prions cause non-Mendelian inheritance in budding yeast, and sometimes act as diseases of yeast. We report the
bioinformatic construction of the PrionHome, a database of .2000 prion-related sequences. The data was collated from
various public and private resources and filtered for redundancy. The data was then processed according to a transparent
classification system of prionogenic sequences (i.e., sequences that can make prions), prionoids (i.e., proteins that propagate
like prions between individual cells), and other prion-related phenomena. There are eight PrionHome classifications for
sequences. The first four classifications are derived from experimental observations: prionogenic sequences, prionoids,
other prion-related phenomena, and prion interactors. The second four classifications are derived from sequence analysis:
orthologs, paralogs, pseudogenes, and candidate-prionogenic sequences. Database entries list: supporting information for
PrionHome classifications, prion-determinant areas (where relevant), and disordered and compositionally-biased regions.
Also included are literature references for the PrionHome classifications, transcripts and genomic coordinates, and structural
data (including comparative models made for the PrionHome from manually curated alignments). We provide database
usage examples for both vertebrate and fungal prion contexts. Using the database data, we have performed a detailed
analysis of the compositional biases in known budding-yeast prionogenic sequences, showing that the only abundant bias
pattern is for asparagine bias with subsidiary serine bias. We anticipate that this database will be a useful experimental aid
and reference resource. It is freely available at: http://libaio.biol.mcgill.ca/prion.
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Introduction
Prions are alternative, propagating states of normal cellular
proteins, that propagate from organism to organism, through
infection or inheritance. Prions were originally defined as the
causative agent of mammalian transmissible spongiform enceph-
alopathies (TSEs), diseases which include scrapie in sheep and
Creutzfeldt-Jakob disease (CJD) in humans [1]. CJD involves
progressive dementia, and death within a year of diagnosis. TSEs
can arise in inherited, sporadic or infectious forms. Infectious
prions lack nucleic acids [1], and rely on the presence of a host
prion-protein gene for propagation [2]. Whereas the normal
cellular form of the prion protein (PrP-C) is mostly alpha-helical
[3] [4], the infectious form of the prion protein (PrP-Sc), is mostly
beta-sheet [5], which indicates a dramatic conformational change
in the infectious protein.
The prion protein (PrP) is highly conserved across mammals,
typically with .50% sequence identity relative to human PrP [6]
[7]. PrP maintains very high sequence conservation (.95%) in
regions associated with disease, and also conserves a metal ion–
binding repetitive region whose copy number is implicated in
some human prion diseases [8], and which is intrinsically
disordered when not bound to metal ions [9]. Mammalian PrP
paralogs have continued to be discovered and have been
demonstrated to be of neurological relevance and functionally
linked to PrP [10]. Doppel is a divergent PrP homolog (,25%
sequence identity), that is mainly expressed in the testis, and can
cause neurodegeneration when aberrantly expressed in the central
nervous system (CNS) [10]. A second paralog of PrP, dubbed
Shadoo, is more highly conserved across vertebrates, than either
Doppel or PrP. Shadoo intriguingly shares a high degree of
sequence identity with PrP in the short alanine-rich stretch that
forms a transmembrane alpha-helix in some disease-associated
PrP products [11]. Shadoo is expressed in the CNS, and both
Shadoo and PrP-C can counteract Doppel neurotoxicity in a
similar way [12]. Furthermore, down-regulation of Shadoo
indicates a pre-clinical event in the response to prion infection
[13]. PrP homologs have also been observed in fish [14], and
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31785extensive genome-scale analyses in vertebrates have led to the
discovery of additional gene and pseudogene family members for
PrP [15]. Moreover, distant homology to ectodomains in the ZIP
family of proteins linked to cytosolic divalent metal ion import,
indicates that the PrP gene family may have originated from an
ancestral ZIP sequence in an early common metazoan ancestor
[16].
Apart from the original infectious prion phenomena just
described, prions have been defined in other organisms. In the
budding yeast S. cerevisiae, prions have been identified as
cytoplasmic or nuclear elements inherited in a non-Mendelian
fashion [17] [18] [19]. The first two yeast prions discovered were
[PSI
+] and [URE3] [17] [18] [19]. [PSI
+] arises from propagation
of a misfolded amyloid form of Sup35p, part of the translation
termination complex. Formation of [PSI
+] prions reduces the
efficiency of translation termination and increases levels of
nonsense-codon readthrough [18]. Such readthrough has been
demonstrated to be a potential mechanism to uncover cryptic
genetic variation [20] [21]. [URE3], the prion form of the
nitrogen catabolism protein Ure2p, functions to up-regulate poor
nitrogen source usage, even when rich sources are available [17].
Prions may also be considered as diseases of budding yeast, in
certain contexts [22] [23]. A defining characteristic of the known
yeast prions is a region with an obvious bias for asparagine (N)
and/or glutamine (Q) residues [24] [25] [26] [27]. Mutation of
these residues reduces the ability of proteins to add onto wild-type
prion aggregates [26] [27]. Indeed, randomization of the
sequences of prion-determinant domains for [PSI
+] and [URE3]
does not block prion formation [28] [29], and prion formation
propensity in N/Q-rich domains can be predicted with reasonable
accuracy solely using amino-acid composition [30]. These biases
are linked to protein disorder; the prion determinant regions of
both Ure2p and Sup35p are intrinsically disordered in their native
forms [31] [32]. Previously, we have shown that these N/Q biases
are maintained in fungi that are estimated to have diverged from
each other ,1 billion years ago; furthermore, there is evidence for
purifying selection, to varying degrees, on different prion domains
or subdomains [33]. Several hundred prion-like domains (with
pronounced bias for N, Q and other subsidiary biases) occur in the
proteomes of diverse fungi and higher eukaryotes [24] [33] [34].
N/Q-rich domains also form aggregates in other contexts; the
protein CPEB from the sea-slug Aplysia has a prion-like domain
which can behave like a prion in budding yeast, which also forms
aggregates within Aplysia neuronal cells, and which may function
in long-term memory formation [35] [36]. Other N/Q-rich
domains are implicated in human diseases and form aggregates
(e.g. TDP-43 and FUS [37]). Recent work indicates that N residues
tend to be more enriched in prionogenic domains, and that Q bias
(such as that observed in the Sup35p prion determinant) is less
usual [38].
The universe of prion phenomena continues to expand in
budding yeast [38] [39] [40] [41] [42], and in other fungi, i.e, the
Het-S prion in Podospora anserina [43]. For example, in budding
yeast, a prion that is formed by the Cyc8 protein is part of a
transcriptional regulatory complex that regulates 7% of yeast
genes, thus potentially regulating their expression en masse [44].
Although the vast majority of described prions arise via
propagation of alternative amyloid states of proteins, other types
of prions are possible, such as the [ß] prion, which arises through
propagation of the auto-activated state of yeast protease B [45].
Also, some amyloids, dubbed ‘prionoids’, exhibit evidence of cell-
to-cell propagation of aggregates in some contexts or experimental
conditions, and may demonstrate limited organism-to-organism
propagation in experiments [46]. For example, the prionoid
SOD1, whose amyloid formation is implicated in amyotrophic
lateral sclerosis, has been shown to propagate from cell to cell in a
neuro-2a cell system [47]. Other prion-related phenomena, which
involve propagation of aggregates of prion-related domains within
cells, or within model systems (e.g., CPEB, FUS or TDP-43
mentioned above), are also increasingly being reported and
utilized for research into the contribution of aggregate formation
to disease and protein function.
Here, we report the bioinformatic derivation of a classification
system for prion–related sequences, which is used for the
computational construction of a public-domain resource, the
PrionHome database. This database enables tracking of the
rapidly growing corpus of prion phenomena and prion-related
sequence data. The PrionHome comprises collated and curated
information about prions, prionogenic sequences, ‘prionoids’,
prion protein orthologs and paralogs, prion-related pseudogenes
(i.e., genes copies that appear to have lost their protein-coding
ability), prion protein interactors and candidate-prionogenic
sequences predicted from compositional analysis. The database
entries contain information about prion determinants, composi-
tionally-biased and disordered regions, protein interactors, protein
structures, genomic coordinates, key citations, and comments
supporting the classification of the sequences in the database. We
demonstrate the utility of the database in examining relationships
between prion-related molecules, through sequence compositional
analysis of the database data.
Materials and Methods
Database structure
The PrionHome database is a record-based database, similar in
format to the DisProt database [48]. It is managed and updated
using the SQL and PHP scripting languages. The individual
database entries are for single sequences. A screen-shot example is
depicted in Figure 1. This is the database entry for a duplicated
transcribed pseudogene in the human genome that is homologous
to Sprn, the gene encoding the Shadoo protein. Database entries
are indexed by Prion Identifier (which is in the form PDxxxx,
where xxxx is a four-digit number), and also by PrionHome
Classification (which is explained below in the section describing
the database entry format).
Overview of data collation and curation
The sequence data is derived from several sources (Figure 2).
The first source is a set of annotations (made by the authors) of
Prion Protein Family relatives, including pseudogenes, and distant
homologs not detectable by standard sequence alignment [15]
[16]. Also, protein sequences were extracted from the UniProt
database using keyword searches for relevance to prion phenom-
ena, using sequence homology searches to known prion-related
protein sequences, and also using our previous knowledge of
prions, prionoids, and other prion-related protein sequences.
These were filtered appropriately for redundancy, or sometimes
updated using genomic sequence data where they were originally
derived from translations of incomplete transcripts. Furthermore,
some additional sequences for pseudogenes were taken from NCBI
nucleotide sequence databases.
To put the sequences into their appropriate PrionHome
classification categories, a variety of data sources were applied.
Information about prions, prionoids and other prion-related
phenomena was collated from the literature. Protein interaction
data was extracted from the EBI IntAct database [49]. Orthologs
and paralogs were calculated using simple sequence comparison
with BLAST [50], where they had not already been inferred in
A Prion Biology Data Resource
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31785Figure 1. A screenshot of an entry in the PrionHome database, for the Shadoo transcribed pseudogene in the human genome.
doi:10.1371/journal.pone.0031785.g001
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PrionHome classifications in the Database Entry Format section
below). Candidate-prionogenic sequences were refined from
previous annotations of ‘prion-like’ domains by the authors [33]
[51], and also are taken from predictions made using an Hidden
Markov Model (HMM) algorithm by Alberti, et al. [38]. More
specific details of the data collation and curation, where relevant,
are listed below in the database entry format section, along with
descriptions of the data sources and methods used for annotations
within the database entries.
Database Entry Format
There are nine sections for each database entry. Further details
about database entry format can be found on the help page of the
database. The database entry sections are as follows:
(i) General Information
This first section contains general identifying information: a
PrionHome database ID in the form PDxxxx, where xxxx is a
four-digit number; UniProt identifiers (some PrionHome entries
do not have such identifiers, e.g., new genome annotations for
Prion Protein homologs or pseudogenes); source organism and
taxonomy information; sequence length; protein name; the
complete protein sequence, and the prion name, where relevant.
The prion name field only applies to ‘prionogenic’ sequences, i.e.,
sequences that can make prions. The name of the prion
phenomenon for which the sequence is prionogenic is indicated.
Prion names follow the standard convention for prions in fungal
genetics [52]. The original pathogenic prion in mammals has been
given the name [PrP TSE prion]. Entries labeled ‘Alberti, et al (2009)
data’, are proteins from the analysis of Alberti, et al. [38], which
were indicated as likely prions via a combination of fluorescence
microscopy, SDD-AGE analysis, Sup35C heritable-switch prion
assay and in-vitro assembly assay [38]. In addition, for each prion
name, the prion type is given. Prions are classified into two types, as
follows:
Type Am: The prion state of the protein is a an alternative
conformational amyloid isoform.
Type Ac: The prion state is an activated state of an enzyme, or
other protein or protein complex.
(ii) PrionHome Classification
This section of the database entry contains the PrionHome
classification, as well as a short description of the supporting
information for this classification. The total numbers of entries
with each PrionHome Classification is summarized in Table 1.
The PrionHome classification system consists firstly of four
classifications derived from experimental data, and secondly four
Figure 2. A flow-chart showing a summary of the data collation and curation.
doi:10.1371/journal.pone.0031785.g002
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can be one or more of these listed below:
Prionogenic: A protein sequence that is known to form prions.
These were collated by the database authors from the literature.
Currently here, we define a prion as any unit of propagation of an
altered state of a protein or proteins; the prions are made from an
endogenous protein, expressed in the cells of an individual
organism; they are either propagated by infection into other
individual organisms, or by inheritance to progeny organisms. A
graphical depiction of this definition of prion transmission is shown
in Figure 3.
Prionoid: A protein with a altered conformational state, which
demonstrates cell-to-cell propagation, in the absence of evidence
for natural organism-to-organism infectivity (Figure 3). The
definition of the term ‘prionoids’ is coined and discussed in the
review Aguzzi and Rajendran [46]. Here, we restrict our definition
to proteins from multicellular organisms. Some prionoids
demonstrate experimental organism-to-organism transmission.
Other prion-related phenomenon: A protein that has some behaviour
like a prion, but does not fit the definition of prion or prionoid. For
example, the MAVS protein forms aggregates that propagate
intracellularly in response to viral infection; also, MAVS
aggregation can be ‘seeded’ by introduction of aggregates
previously made in vitro [53].
Interactor: Proteins shown to interact with a prionogenic protein.
Data in this first release of the PrionHome database are restricted
to entries listed as binary interactors of prionogenic proteins, taken
from the IntAct database [49].
Ortholog: An ortholog of a sequence that is known to form prions
(i.e., of prionogenic sequences). Orthologs are the mutually most
similar sequences in different organisms. These were calculated as
orthologs using the bi-directional best hits approach. Some
orthologous proteins are from novel genome annotations,
annotated in Harrison, et al. (2010) [15]. Orthologs for yeast
prionogenic sequences are only calculated for complete fungal
proteomes. Orthologs of the Het-S prion-determinant domain
were detected via remote homolog detection techniques, and
modelled in 3D by protein threading [54].
Paralog: A paralog of a sequence that is known to form prions.
Paralogs are duplications of protein sequences within the same
genome. Some orthologous proteins are from novel genome
annotations, annotated in Harrison, et al. (2010) [15]. ZIP metal-
ion import proteins that contain a Prion Protein -related domain,
that were detected through sensitive Hidden Markov Model
analysis [16], are classified as paralogs in the PrionHome database.
Pseudogene: A copy of a prion-related gene that is formed via
retrotransposition, or other processes of duplication, followed by
coding-sequence disablement [55]. These annotations were taken
from Harrison, et al. (2010) [15], and other literature.
Candidate-Prionogenic Sequence: A protein sequence that contains a
domain that is a candidate for being prionogenic, but that has not
been shown to be prionogenic experimentally. Candidate
Prionogenics have two categories:
(i) N/Q-biased: These have domains with an obvious bias for
glutamine and/or asparagine residues, with optional contrib-
uting biases for glycine, serine and tyrosine, and biases against
chargedand hydrophobic residues, as observed in the first four
described yeast prions. These were determined using the
binomial probability minimization algorithm described in the
ref. [51], with a maximum binomial P-value of 1610
210.
These Candidate-Prionogenic proteins are biased purely for N
and/or Q residues, or for N and/or Q residues with a
subsidiary compositional bias for Y, S or G (with P-
value,1610
24), and do not have contributing biases from
charged residues {DERK} or major hydrophobic residues
{VILM}, with P-value,1610
24. These criteria were derived
from analysis of the four first yeast prion determinants that
were determined (Sup35p, Ure2p, Rnq1p and New1p). All of
the amyloid-based (i.e., Type Am) prionogenic sequences in
budding yeast have domains with N/Q bias.
(ii) Alberti-HMM: These are predicted by the HMM algorithm
used in Alberti, et al. [38], trained on the first four described
yeast prion determinants (in Sup35p, Ure2p, Rnq1p and
New1p).
These definitions of Candidate-Prionogenic refer exclusively to
prions from budding yeast, and not to those from P. anserina or from
mammals. The latter prions are made largely from hydrophobic
domains. The Alberti-HMM data set contains 35 further Candi-
date-Prionogenic sequences that were not covered by the data set
derived from analysis of N/Q bias and other compositional biases
[51]. The two methods used to define candidate prionogenic
sequences are thus complementary in providing greater coverage
for detection of possible prionogenic cases. The HMM algorithm is
trained specifically on four prion determinants, and may miss cases
that look less like these four determinants, but which may be
detected using more general compositional principles defined using
the bias probability-minimization algorithm.
The categories of ‘N/Q-biased’ or ‘Alberti-HMM’ for Candi-
date-Prionogenic sequences are listed in brackets after the
PrionHome classification designation in each database entry.
Sequences in both categories are labelled ‘N/Q-biased, Alberti-
HMM’.
(iii) Prion Determinant
This is the part of the protein sequence that forms the prion
determinant, i.e., that is required for prionogenic activity. In this
section, the method of determination for the prion determinant
(curated from the literature), and its start and end points in the
sequence, are indicated. In some cases the prion determinant is
determined algorithmically [38] [51].
(iv) Compositionally-Biased (CB) Regions
These are regions of the protein sequence that have a bias
towards a subset of amino-acid residue types. They are defined
using the algorithm described in refs. [24] [51] [56]. In this section
Table 1. Summary of database content.
PrionHome Classification
Number of
Database Entries
Prionogenic 51
Prionoid 6
Other prion-related phenomenon 10
Interactor 460
Ortholog 958
Paralog 205
Candidate-Prionogenic 411
Pseudogene 13
TOTAL* 2003
*This is not an arithmetic sum of the individual PrionHome Classification
categories, since some database entries have multiple PrionHome Classifications.
doi:10.1371/journal.pone.0031785.t001
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sequence; the binomial P-value for the CB region; the ‘signature’
of the compositionally-biased region. In the signature are listed the
one-letter codes of amino-acid residue types that define the biased
region, in decreasing order of importance [51]. That is, ‘NY’
indicates a region that is rich in N and Y. All compositional biases
with binomial P-value,=10
27 are listed.
(v) Known Disordered & (vi) Predicted Disordered
Regions
Known disordered regions are taken from the DisProt database
[48]. The ID from the DisProt database, and the start and end
positions of the disordered region in the protein sequence are
listed. Other disordered regions are predicted using the DIS-
OPRED algorithm, and default parameter values [57]. The start
and end positions of the predicted disordered region in the protein
sequence are listed.
(vii) References and Comments
References were curated from the literature. Original references
are given that describe the demonstration of a prionogenic
determinant, or, if not appropriate, for the sequencing of a
prionogenic sequence, or ortholog or paralog. Additional references
are provided if the sequence has been updated, or if additional
significant sequence annotationsarederived.Original references for
the determination of interactors are also given. Comments on the
other sections of the database entry are recorded in this section.
Specifically also, for any sequence database entry, are listed the
PrionHome Database identifiers (PDxxxx) of other sequences in the
database, for which that sequence is an interactor, paralog or
ortholog.Forexample,if PD8888 is aninteractor of the prionogenic
sequencePD7777,thentheterm,‘Interactswith PD7777’islisted in
the Comment section of the entry for PD8888, and vice versa.T h e
terms ‘Ortholog of PDxxxx’ and ‘Paralog of PDxxxx’ are used in a
similar way.
(viii) Genomic Information
In this section, we list the transcripts IDs (taken from the EMBL
database); and the coordinates of the gene of the protein sequence
in a recent genome assembly. These genome coordinate
annotations are taken from the work in Harrison, et al. (2010)
[15], or otherwise transferred from the Ensembl database [58].
Listed are the name of the genome assembly, the chromosome,
strand direction and start and end points of each exon.
(ix) Structure Information
Coordinates of structures for the PrionHome database entries
are listed here. These are either experimental structures, or
comparative models. Experimental structures are taken from the
PDB [59]. They are colour-coded according to the source of the
data (Red for NMR spectroscopy; Green for X-ray crystal
structure; Magenta for EM (Electron Microscopy); and Blue for
a comparative model). Comparative models were made using the
program MODELLER [60] for PrP-related proteins for which the
sequence alignment cannot be made automatically. These proteins
occur in fish species, and tend to have large, interspersed
disordered loops.
Results and Discussion
User Interface
The user interface is designed so that investigators can select
and download subsets of prion-related sequence and annotation
data, that are of interest. A comprehensive ‘Help’ page is provided.
The database can be accessed by:
Figure 3. A graphical depiction of how transmission differs for prions and prionoids, as defined in the database. A key that explains the
symbols in the figure is included.
doi:10.1371/journal.pone.0031785.g003
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browse the complete listing of PrionHome database entries
and select any entries that they want. The selected entries can
then be downloaded in complete database entry format,
FASTA format (i.e., just the protein sequence), or as a
CLUSTALW multiple sequence alignment [61], using the
labeled buttons on the bottom of the display page.
(ii) Searching: Users can‘Search’ either by keyword, by SQL query,
or by BLAST interface. For keyword search, the database or
field in which to search must be selected from a pull-down
menu. For searching the sequences in the database, users can
specify a regular expression of the sort used by the ELM
database of linear motifs [62]. A screenshot of a keyword
search result for the phrase Anolis (a lizard) in the ‘Organism’
field is shown inFigure4. Database entries canbe downloaded
in one of three formats (complete database entry format,
FASTA format or CLUSTALW multiple sequence align-
ment), as detailed above for ‘Browsing’. For searching the
databaseusingtheBLAST querybox,the usercaneitherpaste
in a single sequence in FASTA format, or upload one from a
file, and then specify the parameters of the BLAST search.
In addition, on the home page, there are links to convenient lists
of database entries, grouped by: (i) Prion Name, (ii) PrionHome
Classification, (iii) Organism, and (iv) Supporting Information for
PrionHome Classification. In some cases, the database entries
belong to more than one PrionHome Classification. For example,
there are eleven database entries that are classified as both
‘Paralog’ and ‘Interactor’. There are separate links for these
database entries that have multiple PrionHome Classifications. A
‘PrionHome News’ window is also provided, in which updates and
changes to the PrionHome database are documented.
Examples of Database Usage
We anticipate that the database will be useful as a reference
resource for prion biologists, since it enables access to curated, up-
to-date listings of a variety of prion-related sequences. In addition,
the database will be useful to investigators as a bioinformatic aid to
experimental design. Database entries contain cross-references to
other database entries (that are interactors or homologs), and to
relevant entries in other databases (e.g., DisProt [48]).
Database entry browsing can be informative for experimental
design. For example, examination of the interactors of Ure2p, the
protein that forms the [URE3] prion, produces some interesting
results. The entry accession for Ure2p, the protein that forms the
[URE3] prion, is PD0040. As instructed in the Help page, to find
PD0040 interactors ,we perform a keyword search in the
‘Comment’ field for ‘Interacts with PD0040’. By doing this, we
find a list of 70 proteins that interact with Ure2p. Browsing
through these, we find several that are also candidate prions
according to the survey of Alberti, et al. [38], e.g., the PrionHome
database entry PD0734. This is the G-protein-coupled receptor
GPR1, which was shown, via the dihydrofolate reductase
reconstruction technique, to interact with Ure2p [63]. The
database entry indicates that the GPR1 protein contains a long
(.60 amino acid residues) region that is compositionally-biased for
asparagine, similar to the prion determinant in Ure2p. The
fragment of the GPR1 protein that has prion-like composition has
been shown to efficiently induce [URE3] prion formation [43].
This protein can thus work as a prion ‘cross-seeder’, a potentially
promiscuous mechanism through which prions can act as inducers
of each other [43] [64]. Another interactor and potential cross-
seeder of Ure2p found in the database is MSN1 (PD0729), which
encodes a candidate-prionogenic domain of ,100 residues long.
In Table 2, we have presented some data analysis of prion-
related sequences resulting from queries to the PrionHome
database, made using the SQL query interface. Firstly, for
Table 2, we queried the PrionHome database for mammalian
sequences of the Prion Protein (PrP) family, that have the sequence
motif ‘YYR’. This motif is an epitope for an antibody that is
specific for the disease-related prion form of the PrP protein, PrP
Sc
[65]. We find that all of the PrP sequences that have so far been
shown to be prionogenic, retain this YYR sequence motif, as well
as the substantial majority of other sequences orthologous to PrP
(Table 2). However, none of the paralogous sequences contain this
tripeptide (Table 2).
In Table 3, we investigated the composition of prion-related
domains in Saccharomyces cerevisiae (budding yeast). Known amyloid-
type (Type Am) prionogenic sequences in S. cerevisiae tend to have a
pronounced bias for asparagine and/or glutamine residues [33]
[51]. Subsidiary biases (e.g., for aromatic residues or serines and
threonines) may also be important for honing prion propagation
Figure 4. An example of the results of a keyword search, for the term ‘Anolis’ in the ‘Organism’ field. Five entries for Anolis caroliensis (a
lizard), appear listed.
doi:10.1371/journal.pone.0031785.g004
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of the Sup35p prion determinant domain indicated that prion
domains can be stabilized by hydrogen bonds between Q and N
sidechains [66]. Also, sidechains that contain six-membered rings,
such as phenylalanine (F) and tyrosine (Y) may be able to interact
in an arrangement termed p stacking [67]. Tyrosine residues in
glutamine-rich domains improve the fragmentation of amyloid
fibrils made from these domains, leading to more efficient amyloid
propagation in the absence of Rnq1/PIN or sometimes Hsp104
[68]. Toombs, et al. showed that phenylalanine, tryptophan and
tyrosine residues have very high prion formation propensities [30].
In [PSI
+] prions, aromatic side-chain interactions outside of the
amyloid core cause oligomerization that leads to formation of
prion strain conformations with more limited amyloid cores [69].
We checked how many of the prionogenic and candidate-
prionogenic sequences from budding yeast in the PrionHome
database also have a compositional bias for F or Y residues
(Table 3). A substantial fraction of the domains classed as
prionogenic contain an F/Y compositional bias (6/25, 24%).
Also, a smaller fraction of candidate-prionogenic domains (as
defined in Database Construction & Content), contain an F/Y
compositional bias (90/377, 13%). Thus, these domains could
use p stacking for amyloid stabilization, in addition to asparagine
and glutamine sidechain hydrogen-bonding interactions; also, they
could also have increased fibril fragmentation, in cases with the
highest F/Y biases [68]. There is a depletion for this compositional
feature for a set of candidate-prionogenic sequences that were
experimentally shown not to form amyloids (Table 3) [38]. These
data thus suggest that a subsidiary F/Y bias has a generally
positive effect on prionogenesis.
To probe further the compositional details of the budding-yeast
amyloid-type prionogenic sequences, we have performed a case-
by-case statistical analysis of the main and subsidiary biases in each
sequence (Table 4). The biases for each sequence were calculated
as described in the section on Database Construction & Content, using
the lowest-probability subsequence algorithm [51]. Of the eight
well-characterized prionogenic sequences, five have a predomi-
nant N bias ([NU+], [ISP+], [MOT3+], [SWI+] and [URE3]),
and three a predominant Q bias ([RNQ+], [PSI+], [OCT+]).
Adding in the seventeen further prionogenic sequences from ref.
[38], gives us a total of 18/25 with predominant N bias, and 7/25
with predominant Q bias. Aplysia CPEB is also Q-rich and behaves
as a prion in yeast cells [35] [36]. Thus all of the known amyloid-
type prionogenic sequences have a predominant N or Q bias, but
there is an obvious general preference for Ns over Qs. Recent
experimental analysis indicates that N residues promote formation
of propagatable amyloid, while Qs induce formation of other non-
prion conformers. Halfmann et al. substituted Qs in prionogenic
sequences with Ns and vice versa [70]. Prionogenic sequences with
Qs replaced by Ns are likely to form prions as well, whereas
prionogenic sequences with Ns substituted for Qs do not form
prions [70]. These data suggest that the encoding of prionogenesis
in Q-rich sequences is more dependent on specific subsidiary
biases and sequence patterns, than in N-rich prionogenic
sequences. Interestingly, here, subsidiary N bias occurs in four of
the seven prionogenic sequences that have a main Q bias.
We also assessed the most common of the strongest subsidiary
biases that occur in the prionogenic sequences in Table 4 (i.e., the
strongest biases in each region after the main bias). There are only
three patterns that occur more than once: A main N bias, with a
strongest subsidiary bias of S occurs 8/25 times; also a Q bias with
a strongest subsidiary Y bias occurs twice, as does a Q bias with a
strongest subsidiary N bias. These results suggest that experimental
investigation into the role of subsidiary serine bias in prion
determinants may be informative.
Relationship to other databases
There are no other published, currently maintained databases
for prions and for the wide array of prion-related sequences that
are encompassed in PrionHome. Two related published databases
do however exist. The Prion Disease Database (PDDB) is a
repository of time-course mRNA measurements and other large-
scale systems biology data for genes that may change behaviour
Table 2. Counts of mammalian sequences in the PrionHome
database with the sequence motif tyrosine-tyrosine-arginine
(YYR).
PrionHome
Classification
# of sequences with
the YYR sequence
motif
# of sequences
without the YYR
sequence motif
Prionogenic PrP sequences
(Major Prion Protein)
20 0
Orthologs of Major Prion
Protein
413{ 9
Paralogs of Major Prion
Protein
0 120
{As an example, the SQL query to obtain this data is: SELECT prion_id , name
FROM main WHERE sequence REGEXP ‘YYR’ AND prion_type=‘Ortholog’ AND
taxonomy LIKE ‘%mammal%’.
doi:10.1371/journal.pone.0031785.t002
Table 3. A summary of prionogenic (Amyloid Prion Type Am) and candidate-prionogenic sequences in the PrionHome database
from Saccharomyces cerevisiae, that have N/Q and F/Y compositional biases.
PrionHome Classification
# of sequences that have N/Q
bias, but no F/Y bias
# of sequences that have
N/Q bias, and F/Y bias*
Prionogenic** 19 6***
Candidate-Prionogenic **** 329 48
Candidate-Prionogenic experimentally shown not to form amyloid***** 16 2
*F/Y compositional biases with binomial P-values,=10
26 are considered (see Database Construction & Content for details).
**This data includes the Alberti, et al. (2009) data from screens for candidate prionogenic sequences.
***As an example, the SQL query to obtain this data is: SELECT prion_id , name FROM main WHERE prion_type LIKE’%prionogenic%’ AND bias REGEXP ‘Y|F’ AND bias
REGEXP ‘N|Q’ AND organism LIKE ‘%cerevisiae%’.
****Polymorphic sequences have been removed from these totals. This is the total list of Prion-Like sequences from Harrison, et al. (2006) and Alberti, et al. (2009).
*****Prion-like sequences that failed to form amyloid by any tests in Alberti, et al. (2009).
doi:10.1371/journal.pone.0031785.t003
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amyloid precursor database, contains listings of a small subset of
prionogenic sequences that have been demonstrated to propagate
through amyloid formation [72]. In the future, we will cross-
reference our database with these two databases, where possible.
Conclusions and Future Developments & Updates
We have reported the bioinformatic construction of Prion-
Home, a comprehensive database resource for prions and other
prion-related molecules. To construct the database, we processed
the sequences according to a transparent ontology of prionogenic
and prion-related protein sequences. We presented some examples
of database utility for prion researchers. We used the data in the
database to perform compositional analysis of prionogenic
proteins in budding yeast, demonstrating prevalent subsidiary
compositional bias patterns. As PrionHome develops further, it
will become increasingly useful for investigators as a reference
database, and also as an aid for further experimental inquiry.
Table 4. Detailed analysis of compositional biases in budding yeast amyloid-type Prionogenic sequences.
Database
Identifier Name and Prion [in square brackets] Compositional biases*
PD0023 Serine/threonine-protein_kinase_CBK1
[Alberti, et al. 2009 data]
188/249/5.4e-46/Q; 85/179/2.2e-12/SNP
PD0026 Prion_formation_protein_1_NEW1 [NU+] 68/94/8.5e-27/NY; 60/103/3.6e-10/Y; 332/417/4.7e-08/SLV
PD0028 Asparagine-rich_protein_NRP1 [Alberti, et al. 2009 data] 391/567/4.7e-56/N; 383/715/1.6e-48/NS
PD0029 SWI/SNF_chromatin-remodeling_complex_subunit_SWI1 [SWI+] 4/322/3.2e-67/N 336/384/1.1e-36/Q; 913/1260/1.6e-20/NSI; 14/31/
8.2e-09/T; 87/298/9.1e-09/S; 592/692/1.0e-08/K; 568/585/1.3e-08/N
PD0033 U6_snRNA-associated_Sm-like_protein_Lsm4 [Alberti, et al. 2009 data] 93/166/6.5e-26/N
PD0034 Uncharacterized_protein_YBL081W [Alberti, et al. 2009 data] 30/353/2.3e-48/NSYHQ; 195/353/1.9e-21/S; 48/153/1.1e-07/Y
PD0035 Nuclear_and_cytoplasmic_polyadenylated_RNA-binding_protein_PUB1
[Alberti, et al. 2009 data]
242/287/4.7e-26/NM; 419/452/1.5e-21/Q; 273/303/8.4e-11/M
PD0040 Protein_URE2 [URE3] 2/78/3.2e-25/N
PD0044 Nitrogen_regulatory_protein_GLN3 [Alberti, et al. 2009 data] 142/630/4.0e-59/NS; 124/617/2.4e-30/N; 146/630/2.7e-26/S; 644/
716/1.7e-10/SN; 68/119/3.1e-08/TD
PD0734 G_protein-coupled_receptor_GPR1 [Alberti, et al. 2009 data] 490/557/2.1e-59/N; 91/288/1.7e-14/IFNYW; 675/736/2.9e-12/KWY;
854/947/4.1e-07/SN
PD0920 Mediator_of_RNA_polymerase_II_transcription_subunit_3
_PGD1 [Alberti, et al. 2009 data]
277/373/7.6e-29/QNM; 256/392/7.1e-14/N; 202/259/2.2e-08/AP
PD0921 Uncharacterized_RNA-binding_protein_YPL184C [Alberti, et al. 2009 data] 5/27/2.7e-27/N; 98/124/1.2e-10/Q
PD2094 global_transcriptional_regulator_Sfp1 [ISP+] 21/517/3.2e-34/NSHIT; 531/554/7.4e-23/D; 3/20/1.34e-07/T; 9/502/
2.5e-07/S; 311/327/3.6e-07/Q; 139/155/4.9e-07/A; 213/517/3.4e-05/
H; 175/202/9.9e-05/Y; 467/490/1.1e-04/D; 556/570/2.1e-04/N; 614/
628/4.4e-04/H; 26/136/5.8e-04/I; 510/525/6.4e-03/S
PD0021 General_transcriptional_corepressor_CYC8 [OCT+] 492/586/2.2e-81/QA; 698/952/7.5e-30/ESTPNAQ; 14/29/2.9e-23/Q;
509/555/4.6e-14/A; 116/373/2.7e-08/YW
PD0022 Uncharacterized_protein_YBR016W [Alberti, et al. 2009 data] 40/100/6.2e-33/QYN; 5/96/1.0e-07/Y
PD0024 Eukaryotic_peptide_chain_release_factor_GTP-binding
_subunit_SUP35 [PSI+]
4/122/1.8e-49/QYNG; 158/221/3.7e-16/EK; 12/112/2.3e-11/Y; 138/
218/7.9e-10/K; 138/218/7.9e-10/K; 4/108/1.1e-08/N
PD0025 RNQ1 [RNQ+]/[PIN+] 123/402/5.6e-82/QNSGY; 185/402/6.5e-16/N; 7/344/7.1e-13/S; 50/
381/1.3e-10/G
PD0027 mRNA-binding_protein_PUF2 [Alberti, et al. 2009 data] 909/1062/2.5e-51/N; 52/486/3.2e-31/SQTNP; 241/470/4.7e-10/Q;
710/756/5.8e-09/LTIN; 854/1015/2.8e-08/SQ; 55/254/6.2e-08/T; 140/
476/8.5e-08/N
PD0031 Zinc_finger_protein_YPR022C [Alberti, et al. 2009 data] 158/319/8.1e-42/Q; 20/472/1.2e-15/NPS; 732/1040/2.8e-09/NI
PD0032 transcription_factor_RLM1 [Alberti, et al. 2009 data] 212/629/4.5e-55/NSP; 228/629/3.4e-18/S; 94/353/3.1e-10/N; 186/
549/8.8e-10/P; 451/475/1.5e-08/Q; 119/133/2.6e-07/D
PD0036 transcriptional_activator/repressor_MOT3 [MOT3+] 4/488/4.4e-45/NH; 7/34/3.0e-26/Q; 231/337/2.1e-10/P; 4/396/1.4e-
09/H; 431/449/2.6e-07/AS
PD0037 Serine/threonine-protein_kinase_KSP1 [Alberti, et al. 2009 data] 538/939/4.7e-33/NSH; 53/83/1.3e-10/D; 590/972/1.5e-08/S; 454/494/
9.6e-08/K
PD0038 Nucleoporin_ASM4 [Alberti, et al. 2009 data] 52/496/5.7e-25/NS; 18/48/4.8e-15/Q; 52/426/2.4e-07/S
PD0043 Nucleoporin_NSP1 [Alberti, et al. 2009 data] 1/515/8.1e-54/NSTFAG; 288/642/7.3e-19/KD; 80/553/2.5e-12/S; 4/
280/1.1e-09/T; 63/551/1.5e-08/F; 656/797/2.0e-08/NQ
PD2217 transcriptional_regulatory_protein_SAP30 [Alberti, et al. 2009 data] 25/57/4.6e-30/N
*The biases are in the following format: start point/end point/binomial P-value/bias signature. Residues contributing significantly to the bias are sorted in decreasing
order of precedence, i.e., for the bias signature NSHIT, N is the main bias, S is the most important subsidiary bias, and so on. NS biases are in bold text. All biases with P-
value,=10
26 are listed.
doi:10.1371/journal.pone.0031785.t004
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polymorphism data for all entries in the database, some of which
are not deposited in existing standard databases for protein
sequence and genetic variation. We are currently performing
quality control on the polymorphism data, and it will be added to
the second version of the database in the near future. Also, the
literature will be curated for new or overlooked reports of
interactors of prionogenic proteins. The database will be updated
on a weekly basis to incorporate user-submitted data, to add new/
overlooked data, and to cover new prions and prion-related
phenomena, as they are discovered. More detailed comments, and
more comprehensive lists of literature references, will also be
added to the database entries, on a regular basis. Links to other
databases will be checked regularly for new or changed source
data.
As development of this resource is on-going, we will be very
happy to receive and act on any constructive comments from peer
scientists in the areas of prion biology and protein misfolding,
either by email or via the ‘FeedBack’ page on the PrionHome
website.
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